ImmunoGen
Roche Nabs FDA Approval for Ventana Test as CDx for Elahere
The immunohistochemistry-based test detects the folate receptor 1 protein that is over-expressed in most ovarian cancers.
The immunohistochemistry-based test detects the folate receptor 1 protein that is over-expressed in most ovarian cancers.